Stay updated on Cabozantinib for Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublication sourcing language was updated to explain that PubMed publications are automatically filled and may not pertain to the study. The revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page removes a site-wide funding/status notice; the study title, objectives, eligibility, and outcome measures remain unchanged.SummaryDifference0.4%

- Check41 days agoChange DetectedNo additions or deletions detected on the Study Details page (NCT03370718); the page content appears unchanged.SummaryDifference0.4%

- Check63 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check70 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page updates from v3.0.1 to v3.0.2, removing the old revision tag and the 'Back to Top' element. No substantive content changes are indicated.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib for Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.